Financial Network Wealth Advisors LLC Recursion Pharmaceuticals, Inc. Transaction History
Financial Network Wealth Advisors LLC
- $121 Billion
- Q3 2024
A detailed history of Financial Network Wealth Advisors LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 200 shares of RXRX stock, worth $1,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$1,208
Previous $1.5 Million
12.13%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$198 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$152 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$147 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$105 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$92.9 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.09B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...